South32’s $4.7bn Hermosa project clears key US approval as critical minerals push accelerates
IXICO lifts revenue forecast on contract wins and wider client base - UPDATE
SpaceX stock surges in hotly anticipated market debut
Percheron Therapeutics secures proposed WHO drug name for HMBD-002 cancer therapy
Walmart price target lowered by UBS as Q1 results miss elevated expectations
Bram Goorden discusses IXICO growth plans - ICYMI
Zscaler set to benefit from federal tailwinds boosting fourth quarter outlook: analysts
UK utility investors face prolonged uncertainty after worst sell-off since privatisation era
Cavendish sees IXICO forecasts as conservative after order book hits five-year high
Rigetti Computing tops Q1 earnings estimates as loss narrows
IXICO launches latest version of AI neuroimaging platform
IXICO boss says Medidata collab is poster child of partnership plans - ICYMI
Lindian secures US$11.6M facility with Malawian bank to support Kangankunde ramp-up
Dow Jones, Nasdaq close lower as US-Iran peace talks stall, UnitedHealth surges on earnings
Eli Lilly’s Kelonia Therapeutics acquisition seen as strategic bet on next-generation CAR-T: analysts
Rivian Automotive platform push unlikely to gain near-term traction, says UBS
Xcel Energy seen as undervalued as UBS lifts price target
Procter & Gamble cost pressures in focus for Q3 report
McDonald’s Q1 profit seen slightly below estimates as Jefferies trims sales outlook
Halliburton beats estimates as shares rise on early signs of North America recovery
Cavendish sees significant upside in IXICO as surging order book and £10m raise point to growth inflexion
Uranium American Resources completes JAG Minerals acquisition
Biogen to acquire Apellis Pharmaceuticals for $5.6B, adding C3 therapies to portfolio
IXICO boss on 'tech bio' deal that creates solution for clinical trials - ICYMI
Reddit introduces new age and human verification measures
Dow dips, Nasdaq falls as oil surges, Trump says Iran 'better get serious'
IXICO strikes neuroimaging deal with Medidata to expand clinical trial platform
Celsius shares jump on strong fourth quarter results
Nasdaq leads Wall Street higher as 2026 trading kicks off
2026 a pivotal year for consumer internet and e-commerce, says Wedbush
Tower Semiconductor shares held steady by strong silicon photonics demand, Wedbush says
The 5 AI stocks Dan Ives thinks will define 2026
CRISM shares drop as discounted £1m placing funds next trial phase
Microsoft makes $17.5bn bet on India with its biggest ever investment in Asia
Oracle stock pullback creates attractive risk/reward ahead of Q2 report: Jefferies
Gap’s Old Navy beauty push draws praise from Jefferies analysts
Citi says Rio Tinto is building a low-cost lithium platform despite tough market backdrop
Dow Jones reverses, Nasdaq back in positive territory despite big tech wobbles
American Eagle Q3 sales beat estimates, raises full-year outlook
'Code red' at OpenAI as Altman urges rapid upgrades to ChatGPT as rivals step up pressure
IXICO signs £3.5m Huntington's trial contract - ICYMI
Dow leads Wall Street to a negative finish as investors reassess tech
JP Morgan analysts see shoots of growth, and not just among the 'Mag 7' tech stocks
FTSE 100 Live: Blue-chips trade sideways as Wall Street looks flat
IXICO lands £3.5m contract for global Huntington’s trial
IXICO shares rise 4% on stronger-than-expected revenue growth